Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers

Partnership Leverages Epizyme’s Transformational Histone Methyltransferase Inhibitor Platform and Celgene’s Translational …